Colon
The Latest
Practice update: Refractory constipation
-
by Doug Brunk
Longstanding concerns about chronic stimulant laxative use are described as unfounded.
Infliximab levels predict ASUC outcomes
-
by Doug Brunk
Higher early clearance, especially by day 7, was strongly associated with nonresponse, treatment failure, and colectomy.
Task force touts greener endoscopy units
-
by Doug Brunk
Reducing unnecessary procedures, supplies, and ancillary resources offers the greatest environmental benefit relative to effort.
AGA strengthens payor ties to ease admin burden
-
by Doug Brunk
“We view this as an opportunity to work together to alleviate some of these burdens, and I will say that hearing the perspective from payors has been very eye-opening.”
Building effective community-based IBD care: Key challenges and opportunities
-
by Doug Brunk
“I fear practices will lose their relevance if they do not start building systems and processes for cognitive care pathways like IBD."
Mirikizumab shows promise for kids with ulcerative colitis
-
by Doug Brunk
"This is the first published clinical trial data on IL-23 inhibitors in children with UC and shows mirikizumab to be safe and effective for this population.”
AGA unveils new clinical practice guideline for Crohn's disease
-
by Doug Brunk
The guidelines are living documents that “will be updated quarterly, allowing for rapid evolution as new data become available.”
ED drugs tied to lower gastric cancer risk
-
by Kerri Miller
Large retrospective study finds 30% reduction in gastric malignancy among men taking erectile dysfunction medications.
Exercise patterns and GI cancer risk
-
by Kerri Miller
Consistently meeting—but not exceeding—recommended activity levels offers maximal protection against digestive cancers, new research suggests.
CRC screening: Smartphone-based stool test matches lab accuracy
-
by Amy Pfeiffer
The findings point to a new tool for enhancing participation in CRC screening programs—particularly among younger, tech-savvy patients under 60 years who demonstrated higher adoption rates.
Microbiome: COVID-19's hidden factor?
-
by Kerri Miller
Pre-pandemic microbiome composition influences severe disease outcomes years later in a population study.
Mediterranean vs traditional diet for IBS
-
by Kathryn Wighton
The Mediterranean diet demonstrated greater symptom relief and patient adherence than traditional dietary advice.
Does ESD equal TAMIS for early rectal neoplasms?
-
by Amy Pfeiffer
“ESD was associated with fewer technical constraints, higher procedural success, shorter hospitalization, lower cost, and greater patient acceptance."
Lower GI mistakes: Postop Crohn's, vaccine gaps, colonoscopy errors
-
by Kerri Miller
"There's no such thing as a routine colonoscopy. Every colonoscopy has a potential for mistakes."
Endoscopist skill found to predict short-term post-colonoscopy cancer
-
by Julian Upton
In the short term, the quality of the endoscopist is a stronger driver of cancer risk than polyp characteristics.
Nutritional IBD screening tools ranked
-
by Kerri Miller
"MIRT might be the NSTs of choice to predict defined malnutrition and low-Fat Free Mass Index at 6 months follow-up in a cohort of inactive/mildly active IBD patients."
It’s not the polyp, it’s the provider: Study
-
by Julian Upton
High-risk polyps are usually considered the main reason for shortened surveillance intervals.
Global IBD trial experts agree on steroid standards
-
by Teraya Smith
New guidance issued on how steroids should be managed in clinical trial settings.
Intestinal ultrasound offers prognostic value in IBD pregnancy
-
by Kerri Miller
"We rely very little on symptoms in pregnancy — they’re so unreliable — and instead target fecal calprotectin under 100 and sonographic remission."
Top 5 tips for becoming an effective gastroenterology consultant
-
by Allon Kahn, MD
Move beyond the notion of the “bad” or “soft” consult and seek instead to understand how you can help.
GLP-1 receptor agonist use in gastrointestinal endoscopy: A review of current evidence and guidelines
-
by Sitharthan Sekar, MD, Nikiya Asamoah, MD
Improving care for patients from historically minoritized and marginalized communities with disorders of gut-brain interaction
-
by Rosa Yu, MD, Jennifer Dimino, MD, Christopher Velez, MD, GI and Hepatology News
An uncertain future for no-cost preventive care
-
by Megan A. Adams, MD, JD, MSc
Despite a new administration, the federal government continues to advocate for upholding the law, asserting that USPSTF members are “inferior officers."
Improving care for sexual and gender minority patients with disorders of gut-brain interaction
-
by Kara J. Jencks, MD, Christopher Velez, MD
Improving care for sexual and gender minority patients with disorders of gut-brain interaction
-
by Kara J. Jencks, MD, Christopher Velez, MD
Surgical vs endoscopic excision of large colon polyps
-
by Gyanprakash A. Ketwaroo, MD, MSc, Moamen Gabr MD MSc, Jeffrey D. Mosko, MD, MSc, Ira Leeds, MD
Clinical research in early career academic medicine
-
by Lauren D. Feld, MD, Kathy Nguyen, Katherine Cooper, MD, Loren Galler Rabinowitz, MD, Amiko M. Uchida, MD
Avoid getting stuck: A practical guide to managing chronic constipation
-
by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS
Avoid getting stuck: A practical guide to managing chronic constipation
-
by Hamza Salim, DO, Anni Chowdhury, DO, Lavanya Viswanathan, MD, MS
The complexity of this condition should be appreciated and understood in order for a complete and thorough evaluation.
Healthcare AI: Balancing safety and innovation
-
by Megan A. Adams, MD, JD, MSc
In this month’s issue of GI & Hepatology News, we summarize a recent systematic review and meta-analysis highlighting worsening health disparities for Hispanic adults with MASLD.
Computational pathology offers insights on colorectal cancer outcomes
-
by Noah Levine
Study uses artificial intelligence to decode spatial cellular patterns in colorectal cancer, offering new tools for personalized treatment.
A paradigm shift in evaluating and investigating the etiology of bloating
-
by Rajan Singh, PhD, Baharak Moshiree, MD, AGAF
Navigating and negotiating maternity/paternity leave in private practice
-
by GI and Hepatology News
The AGA Future Leaders Program: a mentee-mentor triad perspective
-
by Parakkal Deepak, MBBS, MS, Edward L. Barnes, MD, MPH, Aasma Shaukat, MD, MPH
A simplified approach to pelvic floor dysfunction
-
by Ayesha Khan, DO, Raakhi Menon, DO, Lindsay Allen, PT, DPT, MBA, Brooke Corning, MD
Achieving promotion for junior faculty in academic medicine: An interview with experts
-
by Vineet S. Rolston, MD, Sophie Balzora, MD, Mark A. Schattner, MD
What gastroenterologists need to know about the 2024 Medicare payment rules
-
by GI and Hepatology News
The good, bad, and ugly of direct-to-consumer advertising
-
by Sheldon Sloan, MD, David A. Drew, PhD
New and transitioning gastroenterologists face burnout too
-
by Corlan O. Eboh, MD, Victoria Jaeger, DO, Dawn M. Sears, MD, FACG
Increase in message volume begs the question: ‘Should we be compensated for our time?’
-
by Luis M. Nieto, MD, Jami Kinnucan, MD
From private practice to academic medicine: My journey and lessons learned
-
by Katie Hutchins, MD
Recruiting gastroenterology and hepatology fellows virtually - Should we continue after the pandemic?
-
by Lara Dakhoul, MD, Tiffany Rhoden, Virginia Clark, MD
Artificial intelligence applications in colonoscopy
-
by Eugenia N. Uche-Anya, MD, Tyler M. Berzin, MD
Immune checkpoint inhibitor–related gastrointestinal adverse events
-
by Joshua Kwon, MD, Paul T. Kröner, MD, MSc
Why I decided to get an MBA after becoming a private practice gastroenterologist
-
by Vasu Appalaneni, MD, MBA
Integrating intestinal ultrasound into inflammatory bowel disease training and practice in the United States
-
by Noa Krugliak Cleveland, MD, David T. Rubin, MD